Wird geladen...

Randomized Study of Antihypertensive Efficacy and Safety of Combination Aliskiren/Valsartan vs Valsartan Monotherapy in Hypertensive Participants With Type 2 Diabetes Mellitus

In this double‐blind study, 1143 hypertensive participants with type 2 diabetes and stage 1 or 2 chronic kidney disease (CKD) were randomized to receive combination aliskiren/valsartan 150/160 mg or valsartan 160 mg monotherapy for 2 weeks, with force‐titration to 300/320 mg and 320 mg, respectively...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Clin Hypertens (Greenwich)
Hauptverfasser: Bakris, George L., Oparil, Suzanne, Purkayastha, Das, Yadao, Anthony M., Alessi, Thomas, Sowers, James R.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Blackwell Publishing Ltd 2012
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8108251/
https://ncbi.nlm.nih.gov/pubmed/23339726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.12032
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!